ProPhase Labs, Inc.
PRPH
$0.3326
$0.00130.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -67.59% | -80.65% | -96.69% | -90.71% | -80.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -67.59% | -80.65% | -96.69% | -90.71% | -80.90% |
| Cost of Revenue | -58.59% | -64.38% | -79.72% | -75.88% | -68.84% |
| Gross Profit | -91.24% | -100.96% | -114.52% | -104.84% | -90.52% |
| SG&A Expenses | 6.89% | 13.29% | -25.75% | -22.79% | -6.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.19% | -19.22% | -53.33% | -52.97% | -44.52% |
| Operating Income | -16.60% | -82.04% | -123.79% | -375.36% | -457.07% |
| Income Before Tax | -25.33% | -88.99% | -125.97% | -345.48% | -510.58% |
| Income Tax Expenses | 213.53% | 219.56% | -75.67% | -177.12% | -924.35% |
| Earnings from Continuing Operations | -116.79% | -202.35% | -154.06% | -476.43% | -444.39% |
| Earnings from Discontinued Operations | 848.45% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -82.79% | -217.98% | -164.97% | -502.61% | -461.92% |
| EBIT | -16.60% | -82.04% | -123.79% | -375.36% | -457.07% |
| EBITDA | -22.40% | -113.86% | -171.54% | -1,163.20% | -278.53% |
| EPS Basic | -58.96% | -168.46% | -144.53% | -464.41% | -420.87% |
| Normalized Basic EPS | 3.16% | -58.05% | -112.13% | -336.01% | -444.75% |
| EPS Diluted | -58.86% | -168.25% | -145.66% | -459.21% | -501.72% |
| Normalized Diluted EPS | 3.16% | -57.76% | -111.60% | -311.53% | -592.26% |
| Average Basic Shares Outstanding | 35.21% | 12.50% | 9.26% | 8.49% | 7.46% |
| Average Diluted Shares Outstanding | 35.21% | 10.37% | 7.16% | -0.12% | -6.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |